Is there not a better way to prevent venousthromboembolism after total knee arthroplasty?

Authors

DOI:

https://doi.org/10.15674/0030-59872017172-79

Keywords:

total knee arthroplasty, aspirin, mechanical compression mobilization

Abstract

Background: aspirin at 325 mg twice daily is now included as a nationally approved venous thromboembolism prophy­laxis protocol for low risk total knee arthroplasty patients.

The purpose of this study is to examine if there is a difference in deep vein thrombosis occurrence after a limited tourni­quet total knee arthroplasty using aspirin-based prophylaxis with or without extended use of mechanical compression device therapy.

Methods: one hundred limited tourniquet total knee ar­throplasty patients, whose deep vein thrombosis risk was managed with aspirin 325 mg twice daily for 3 weeks, were ran­domized to either utilizing an mechanical compression device during hospitalization only or extended use at home up to six weeks post-op. Lower extremity Duplex venous ultrasonogra­phy was completed on the second post-op day, 14 days post-op, and at 3 months post-op to confirm absence of deep vein thrombosis after treatment.

Results: the deep vein thrombosis rate for the post-discharge mechanical compression device therapy group was 0 % and 23.1 % for the inpatient mechani­cal compression device group (p < 0.001). All deep vein throm­bosis resolved by 3 months postop. Patient satisfaction was 9.56 ± 0.82 for post-discharge mechanical compression device patients versus 8.50 ± 1.46 for in patient mechanical compres­sion device patients (p < 0.001).

Conclusion: limited tourniquet total knee arthroplasty patients that were mobilized early, managed with Aspirin for 3 weeks post-op, and mechanical com­pression device therapy for up to 6 weeks post-op experienced superior deep vein thrombosis prophylaxis than patients receiv­ing mechanical compression device therapy only as an inpatient (p < 0.05). The 0 % incidence of non-symptomatic deep vein thrombosis prevented by Aspirin and extended use mechanical compression device further validates this type of prophylaxis in low deep vein thrombosis risk total knee arthroplasty pa­tients.

References

  1. Westrich GH, Haas SB, Mosca P, Peterson M. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br. 2000;82(6):795–800.
  2. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. Evidence-based guideline and evidence report. 2nd ed. American Academy of Orthopaedic Surgeons, 2011. Available from: http://www. aaos.org/research/guidelines/VTE/VTE_full_guideline.pdf.
  3. Colwell Jr CW, Froimson MI, Anseth SD, Giori NJ, Hamilton WG, Barrack RL, Buehler KC, Mont MA, Padgett DE, Pulido PA, Barnes CL. A mobile compression device for thrombosis prevention in hip and knee arthroplasty. J Bone Joint Surg Am. 2014;96(3):177–83. doi:10.2106/JBJS.L.01031.
  4. Lotke PA, Palevsky H, Keenan AM, Meranze S, Steinberg ME, Ecker ML, Kelley MA. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res. 1996;324:251–8.
  5. Lussana F, Squizzato A, Permunian ET, Cattaneo M. A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty. Thromb Res. 2014;134(3):599–603. doi:10.1016/j.thromres.2014.06.027.
  6. Pellegrini Jr. VD, Sharrock NE, Paiement GD, Morris R, Warwick DJ. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment. Instr Course Lect. 2008;57:637–61.
  7. Reitman RD, Emerson RH, Higgins LL, Tarbox TR. A multimodality regimen for deep venous thrombosis prophylaxis in total knee arthroplasty. J Arthroplasty. 2003;18(2):161–8. doi: 10.1054/arth.2003.50026.
  8. Morris RJ, Woodcock JP. Evidence-based compression: prevention of stasis and deep vein thrombosis. Ann Surg. 2004;239(2):162–71. doi: 10.1097/01.sla.0000109149.77194.6c.
  9. Review: Cothera VPULSE compression and cold therapy system for prevention of deep vein thrombosis and pulmonary embolisms. Medgadget, LLC. 2013. Available from: http://www.medgadget.com/2013/12/review-cothera-vpusle-compression-and-cold-therapy-system-for-prevention-of-deep-vein-thrombosis-and-pulmonary- embolisms.html.
  10. Lachiewicz PF, Soileau ES. Multimodal prophylaxis for THA with mechanical compression. Clin Orthop Relat Res. 2006;453:225–30. doi: 10.1097/01.blo.0000238861.84733.9d.
  11. Lu N, Salvati EA. Multimodal prophylaxis for venous thromboembolic disease after total hip and knee arthroplasty: current perspectives. Chin J Traumatol. 2010;3(6):362–69. doi: 10.3760/cma.j.issn.1008-1275.2010.06.008
  12. Alcelik I, Pollock RD, Sukeik M, Bettany-Saltikov J, Armstrong PM, Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty. 2012;27(3):331–40. doi: 10.1016/j.arth.2011.04.046.
  13. Ejaz A, Laursen AC, Kappel A, Laursen MB, Jakobsen T, Rasmussen S, Nielsen PT. Faster recovery without the use of a tourniquet in total knee arthroplasty. Acta Orthop. 2014;85(4):422–6. doi: 10.3109/17453674.2014.931197.
  14. Gesell MW, Gonzalez Della Valle A, Bartolome Garcia S, Memtsoudis SG, Ma Y, Haas SB, Salvati EA. Safety and efficacy of multimodal thromboprophylaxis following total knee arthroplasty: a comparative study of preferential aspirin vs. routine coumadin chemoprophylaxis. J Arthroplasty. 2013;28(4):575–9. doi: 10.1016/j.arth.2012.08.004.
  15. Likert R. A technique for the measurement of attitudes. New York: The Science Press, 1932. 55 p.
  16. Preston CC, Colman AM. Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. Acta Psychol (Amst.). 2000;104(1):1–15.
  17. Parvizi J, Chen AF, Restrepo C, Uang RH, Cal J. Low dose aspirin: an effective chemoprophylaxis for preventing venous thromboembolic events. Rothman Institute Conference Posters, 2015. Available from: http://jdc.jefferson.edu/ cgi/viewcontent.cgi?article=1009&context=rothinsposters.
  18. Andrawis J, Akhavan S, Chan V. Lehil M, Pong D, Bozic KJ. Higher preoperative patient activation associated with better patient-reported outcomes after total joint arthroplasty. Clin Orthop Relat Res. 2015;473(8):2688–97. doi: 10.1007/s11999-015-4247-4.
  19. Singh JA, Gabriel S, Lewallen D. The impact of gender, age, and preoperative pain severity on pain after TKA. Clin Orthop Relat Res. 2008;466(11):2717–23. doi: 10.1007/s11999-008-0399-9.
  20. Thomas T, Robinson C, Champion D, McKell M, Pell M. Prediction and assessment of the severity of post-operative pain and of satisfaction with management. Pain. 1998;75(2–3):177–85.
  21. Della Valle CJ, Steiger DJ, Cesare PE Di. Thromboembolism after hip and knee arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg. 1998;6(6):327–36.

Downloads

How to Cite

Snyder, M. A., & Vyrva, O. (2017). Is there not a better way to prevent venousthromboembolism after total knee arthroplasty?. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (1), 72–79. https://doi.org/10.15674/0030-59872017172-79

Issue

No. 1 (2017)

Section

ORIGINAL ARTICLES

License

Copyright (c) 2017 Mark A. Snyder, Oleg Vyrva

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).